TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 92 filers reported holding TRINITY BIOTECH PLC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $12,950,000 | +16.6% | 979,600 | 0.0% | 3.92% | +18.9% |
| Q2 2016 | $11,109,000 | -2.7% | 979,600 | 0.0% | 3.30% | -26.5% |
| Q1 2016 | $11,422,000 | -2.9% | 979,600 | -2.0% | 4.49% | -25.4% |
| Q4 2015 | $11,760,000 | +10.8% | 1,000,000 | +7.8% | 6.03% | +35.6% |
| Q3 2015 | $10,616,000 | -34.5% | 928,000 | +3.3% | 4.44% | -2.0% |
| Q2 2015 | $16,218,000 | +3.4% | 898,000 | +10.2% | 4.53% | -8.5% |
| Q1 2015 | $15,690,000 | +29.8% | 815,041 | +18.0% | 4.96% | +13.7% |
| Q4 2014 | $12,090,000 | -11.8% | 690,438 | -7.9% | 4.36% | -11.4% |
| Q3 2014 | $13,700,000 | -13.1% | 749,867 | +9.5% | 4.92% | +3.8% |
| Q2 2014 | $15,768,000 | -4.9% | 684,655 | 0.0% | 4.74% | -13.3% |
| Q1 2014 | $16,589,000 | -2.9% | 684,655 | +0.8% | 5.46% | -3.0% |
| Q4 2013 | $17,078,000 | +16.8% | 679,300 | +1.1% | 5.63% | +0.1% |
| Q3 2013 | $14,625,000 | +32.1% | 672,100 | +2.3% | 5.62% | +25.3% |
| Q2 2013 | $11,072,000 | – | 657,100 | – | 4.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 657,100 | $11,072,000 | 4.49% |
| GOLDMAN CAPITAL MANAGEMENT INC | 343,000 | $5,780,000 | 3.30% |
| Lyon Street Capital, LLC | 368,858 | $6,215,257,000 | 3.08% |
| JAY JEFFREY R | 163,140 | $2,749,000 | 2.17% |
| Adirondack Research & Management Inc. | 161,507 | $2,721,000 | 2.03% |
| Park West Asset Management LLC | 448,415 | $7,556,000 | 0.89% |
| Benchmark Capital Advisors | 51,600 | $869,000 | 0.67% |
| SHEPHERD KAPLAN KROCHUK, LLC | 166,034 | $2,797,000 | 0.55% |
| HEARTLAND ADVISORS INC | 1,569,699 | $26,449,000 | 0.49% |
| WOODMONT INVESTMENT COUNSEL LLC | 86,682 | $1,461,000 | 0.49% |